Browse by Medical Category
Lab Phone: 617-643-5562
MassGeneral Institute for Neurodegenerative Disease (MIND)
Neurology Access Center: 1-855-644-6387
The Gomez-Isla lab focuses on the development and characterization of transgenic mouse models of Alzheimer's disease and on testing novel therapeutic strategies. Research is also conducted with human brain tissue from individuals who suffered Alzheimer's disease while alive.
Dr. Gomez-Isla’s clinical research focuses on cognitively intact individuals across the age spectrum in order to search for molecular mechanisms responsible for individual vulnerability or resilience to this type of dementia.
Teresa Gomez-Isla, MD
Research Lab Members
Genetic cross-interaction between APOE and PRNP
In this work, we investigated for the first time, APOE and PRNP genotypes simultaneously in 474 AD and 175 sporadic CJD (sCJD) patients compared to a common control population of 335 subjects. Differences in genotype distribution between patients and control subjects were studied by logistic regression analysis using age and gender as covariates.
Request a list of currently open positions at email@example.com.
Read about and apply for residency, fellowship and observership programs at http://www.massgeneral.org/neurology/education/.
All applicants should register with the Mass General Careers Web site at http://www.massgeneral.org/careers/viewall.aspx.
MassGeneral Institute for Neurodegenerative Disease
Building 114, Charlestown Navy Yard
How to Apply for Positions
How to apply for jobs: Send an e-mail to firstname.lastname@example.org to receive an automated e-mail with full instructions for all types of positions.
Contact Krista McCabe in the Mass General Development office at 617-726-1392 or KMCCABE@PARTNERS.ORG.
Anne B. Young, MD, PhDDirector, Massgeneral Institute for Neurodegenerative Disease Professor of Neurology, Harvard Medical School
Clinical Appointments, Consultations & Clinical Trials
Please visit the main Neurology Service Contact page for all other contact information.
Back to Top